FIELD: medicine.
SUBSTANCE: patient's pre-therapeutic blood serum is analysed to measure a substance P level. If the substance P level is 2,000 pg/ml and more, a common therapeutic regimen is added with preparations Prednisolone and Milgamma from the first therapeutic day during five days. Prednisolone in a dose of 30 mg is administered orally once a day. Milgamma is injected intramuscularly in a dose of 2 ml once a day.
EFFECT: method enables increasing clinical effectiveness in the patients with rhinosinusitis by enhancing the common routine treatment with reducing the length of pain management.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2580657C1 |
METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF ACUTE RHINOSINUSITIS | 2016 |
|
RU2617044C1 |
METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
METHOD FOR TREATING PATIENTS WITH ALLERGIC RHINITIS ASSOCIATED WITH CHRONIC RHINOSINUSITIS OF BACTERIAL ETIOLOGY USING A DOMESTICALLY PRODUCED TOPICAL IMMUNE CORRECTOR | 2020 |
|
RU2760825C1 |
METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
METHOD FOR DETERMINING DEGREE OF RHINOSINUSITIS SEVERITY | 2015 |
|
RU2611389C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN ACUTE RHINOSINUSITIS | 2010 |
|
RU2438134C1 |
Authors
Dates
2015-09-27—Published
2014-12-03—Filed